Does Endari Replace Hydroxyurea for Sickle Cell?

No, newer sickle cell disease medications like Endari (L-glutamine) do not typically replace the need for hydroxyurea. Instead, they are usually prescribed as “add-on” (adjunctive) therapies to be taken together with hydroxyurea ^[1]. Hydroxyurea remains the foundational daily treatment for sickle cell disease because it addresses the condition in a fundamentally different—and deeply effective—way than the newer drugs ^[2][3].

How Hydroxyurea Works (The Foundation)

Hydroxyurea is considered the “gold standard” for managing sickle cell disease ^[2][4]. It works primarily by prompting your body to produce more fetal hemoglobin (HbF), a type of hemoglobin usually made by babies before birth ^[2][5]. Fetal hemoglobin helps prevent your red blood cells from bending into the stiff, sickle shape ^[6]. By preventing the sickling process at its source, hydroxyurea reduces the frequency of pain crises (vaso-occlusive crises or VOCs) and lowers the risk of severe complications like acute chest syndrome ^[5][4].

Because it takes time for your body to build up fetal hemoglobin, it can take several months of taking hydroxyurea consistently before you notice a significant drop in pain crises.

How Endari Works as an Add-On Therapy

While hydroxyurea changes the type of hemoglobin your body makes, Endari targets a different part of the sickle cell process.

Endari is an amino acid powder—typically mixed into food or liquid twice a day—that acts as an antioxidant ^[7][8]. Sickled red blood cells are under a lot of oxidative stress, which makes them fragile and prone to breaking down ^[8]. Endari helps protect red blood cells from this stress, reducing cell damage and lowering the number of pain crises you experience ^[7][9].

Clinical trials have shown that taking Endari alongside hydroxyurea results in fewer pain crises than taking hydroxyurea alone ^[1][10]. However, Endari can cause side effects—most commonly stomach pain, nausea, constipation, or headache—so you and your doctor will need to weigh these risks against the potential benefits.

Why Combination Therapy Makes Sense

If you are already taking hydroxyurea but still experience occasional pain crises or hospital visits, your doctor might suggest adding Endari ^[1]. Because these medications work through different mechanisms, using them together can offer stronger, layered protection ^[11]. Stopping hydroxyurea to switch to a newer drug could mean losing the vital protective benefits of fetal hemoglobin, which could lead to more frequent and severe pain crises ^[2].

Managing a daily medication routine can be exhausting, and adding another drug can feel overwhelming. It is completely normal to experience “pill fatigue.” Always talk to your hematologist or care team before stopping any medication so they can help you find a safe balance.

A Note on Withdrawn and Curative Therapies

When researching “new sickle cell drugs,” you might come across other names. It is important to know that the FDA continuously monitors drug safety and effectiveness, which means guidelines change:

• Withdrawn Medications: Adakveo (crizanlizumab) and Oxbryta (voxelotor) were once prescribed as add-on therapies. However, Adakveo failed its confirmatory clinical trials ^[12], and Oxbryta was voluntarily withdrawn from the global market in 2024 due to safety concerns and a lack of clear benefits ^[13][14]. They are no longer recommended options.
• Gene Therapies: The truly “new” therapies are Casgevy and Lyfgenia, which were FDA-approved in late 2023. Unlike daily pills or powders, these are one-time gene-editing treatments designed to be curative. They involve a complex, months-long medical process (including chemotherapy) rather than replacing a daily medication like hydroxyurea.